Literature DB >> 26763419

Molecular Genetics of the PI3K-AKT-mTOR Pathway in Genodermatoses: Diagnostic Implications and Treatment Opportunities.

Hassan Vahidnezhad1, Leila Youssefian2, Jouni Uitto3.   

Abstract

A number of critical signaling pathways are required for homeostatic regulation of cell survival, differentiation, and proliferation during organogenesis. One of them is the PI3K-AKT-mTOR pathway consisting of a cascade of inhibitor/activator molecules. Recently, a number of heritable diseases with skin involvement, manifesting particularly with tissue overgrowth, have been shown to result from mutations in the genes in the PI3K-AKT-mTOR and interacting intracellular pathways. Many of these conditions represent an overlapping spectrum of phenotypic manifestations forming a basis for novel, unifying classifications. Identification of the mutant genes and specific mutations in these patients has implications for diagnostics and genetic counseling and provides a rational basis for the development of novel treatment modalities for this currently intractable group of disorders.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26763419     DOI: 10.1038/JID.2015.331

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

1.  PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?

Authors:  Lamis Yehia; Charis Eng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

2.  The Expression of the Endogenous mTORC1 Inhibitor Sestrin 2 Is Induced by UVB and Balanced with the Expression Level of Sestrin 1.

Authors:  Veronika Mlitz; Gaelle Gendronneau; Irina Berlin; Maria Buchberger; Leopold Eckhart; Erwin Tschachler
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

3.  Mice endometrium receptivity in early pregnancy is impaired by maternal hyperinsulinemia.

Authors:  Runqin Li; Juan Wu; Junlin He; Yingxiong Wang; Xueqing Liu; Xuemei Chen; Chao Tong; Yubin Ding; Yan Su; Wenqi Chen; Chen Zhang; Rufei Gao
Journal:  Mol Med Rep       Date:  2017-03-14       Impact factor: 2.952

4.  Shedding light on cashmere goat hair follicle biology: from morphology analyses to transcriptomic landascape.

Authors:  Cristina Nocelli; Katia Cappelli; Stefano Capomaccio; Luisa Pascucci; Francesca Mercati; Irene Pazzaglia; Samanta Mecocci; Marco Antonini; Carlo Renieri
Journal:  BMC Genomics       Date:  2020-07-02       Impact factor: 3.969

5.  Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.

Authors:  Annabel Maruani; Olivia Boccara; Didier Bessis; Laurent Guibaud; Pierre Vabres; Juliette Mazereeuw-Hautier; Sébastien Barbarot; Christine Chiaverini; Sophie Blaise; Catherine Droitcourt; Stéphanie Mallet; Ludovic Martin; Gérard Lorette; Jean-Baptiste Woillard; Annie-Pierre Jonville-Bera; Jérome Rollin; Yves Gruel; Denis Herbreteau; Dominique Goga; Anne le Touze; Sophie Leducq; Valérie Gissot; Baptiste Morel; Elsa Tavernier; Bruno Giraudeau
Journal:  Trials       Date:  2018-06-27       Impact factor: 2.279

6.  Alterations of the MEK/ERK, BMP, and Wnt/β-catenin pathways detected in the blood of individuals with lymphatic malformations.

Authors:  Taehan Kim; Elidia Tafoya; Malcolm P Chelliah; Ramrada Lekwuttikarn; Jiang Li; Kavita Y Sarin; Joyce Teng
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

7.  Expression and significance of mammalian target of rapamycin in cutaneous squamous cell carcinoma and precancerous lesions.

Authors:  Gongjun Xu; Jinxian Fang; Jinlun Xu; Zhen Shen; Chiqing Huang; Yixiu Jiang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 8.  A Review on Cutaneous and Musculoskeletal Manifestations of CLOVES Syndrome.

Authors:  Emel Öztürk Durmaz; Deniz Demircioğlu; Pınar Yalınay Dikmen; Yasemin Alanay; Ahmet Alanay; Cüyan Demirkesen; Fatma Tokat; Ercan Karaarslan
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-13

9.  In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).

Authors:  C Ranieri; S Di Tommaso; D C Loconte; V Grossi; P Sanese; R Bagnulo; F C Susca; G Forte; A Peserico; A De Luisi; A Bartuli; A Selicorni; D Melis; M Lerone; A D Praticò; G Abbadessa; Y Yu; B Schwartz; Martino Ruggieri; Cristiano Simone; Nicoletta Resta
Journal:  Neurogenetics       Date:  2018-03-16       Impact factor: 2.660

Review 10.  Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy.

Authors:  Jean Christopher Chamcheu; Tithi Roy; Mohammad Burhan Uddin; Sergette Banang-Mbeumi; Roxane-Cherille N Chamcheu; Anthony L Walker; Yong-Yu Liu; Shile Huang
Journal:  Cells       Date:  2019-07-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.